Sign in

CIK 0001680581

  • Non-accelerated filer
  • Smaller reporting company

Fulcrum Therapeutics, Inc.

Sign in to watch
Ticker
FULC
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
474839948
Phone
+1 617-651-8851
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2020-05-29 Gould Robert J Sale −1,390 $20.08 $28K 549,036
2020-05-28 Cadavid Diego SVP Clinical Development Exercise or conversion +600 $4.83 $3K 67,385
2020-05-28 Cadavid Diego SVP Clinical Development Sale −600 $20.00 $12K 66,785
2020-05-28 Cadavid Diego SVP Clinical Development Exercise or conversion · Stock Option (right to buy) −600 15,397
2020-05-28 Gould Robert J Sale −1,919 $20.01 $38K 550,426
2020-05-28 Wallace Owen B. Chief Scientific Officer Exercise or conversion +2,232 $7.84 $17K 129,320
2020-05-28 Wallace Owen B. Chief Scientific Officer Sale −2,232 $20.00 $45K 127,088
2020-05-28 Wallace Owen B. Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −2,232 85,034
2020-05-27 Wallace Owen B. Chief Scientific Officer Exercise or conversion +448 $7.84 $4K 127,536
2020-05-27 Wallace Owen B. Chief Scientific Officer Sale −448 $20.00 $9K 127,088
2020-05-27 Wallace Owen B. Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −448 87,266
2020-05-26 Wallace Owen B. Chief Scientific Officer Exercise or conversion +412 $7.84 $3K 127,500
2020-05-26 Wallace Owen B. Chief Scientific Officer Sale −412 $20.00 $8K 127,088
2020-05-26 Wallace Owen B. Chief Scientific Officer Exercise or conversion · Stock Option (right to buy) −412 87,714
2020-05-26 Gould Robert J Sale −2,500 $20.00 $50K 552,345
2020-05-12 Cadavid Diego SVP Clinical Development Exercise or conversion +1,860 $4.83 $9K 68,645
2020-05-12 Cadavid Diego SVP Clinical Development Sale −1,860 $18.00 $33K 66,785
2020-05-12 Cadavid Diego SVP Clinical Development Exercise or conversion · Stock Option (right to buy) −1,860 15,997
2020-05-11 Thomson Peter G. VP Finance & Accounting Sale −7,500 $16.00 $120K 21,071
2020-03-02 Cadavid Diego SVP Clinical Development Sale −1,828 $17.26 $32K 67,100

Page 12 of 15 · 291 trades